Cargando…

Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model

Influenza virus evolves constantly in an unpredictable fashion, making it necessary to vaccinate people annually for effective prevention and control of influenza. In general, however, during the first wave of an influenza outbreak caused by a newly emerging virus strain, influenza morbidity and mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Mei, Qu, Di, Wang, Haiming, Sun, Zhiping, Liu, Xueying, Chen, Jianjun, Li, Changgui, Li, Xuguang, Chen, Ze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926116/ https://www.ncbi.nlm.nih.gov/pubmed/27353250 http://dx.doi.org/10.1038/srep28729

Ejemplares similares

Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
por: Li, Changgui, et al.
Publicado: (2015)

Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
por: Liu, Shanshan, et al.
Publicado: (2018)

Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles–Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung
por: Li, Yumeng, et al.
Publicado: (2019)

Paradoxical modulation of influenza by intranasal administration of non-replicating adenovirus particles
por: Tang, De-chu Christopher
Publicado: (2020)

A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
por: Zhao, Hui, et al.
Publicado: (2018)

Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus
por: Tian, Yabin, et al.
Publicado: (2018)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Protection against Multiple Subtypes of Influenza Viruses by Virus-Like Particle Vaccines Based on a Hemagglutinin Conserved Epitope
por: Chen, Shaoheng, et al.
Publicado: (2015)

Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7
por: Doavi, Tahere, et al.
Publicado: (2016)

Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
por: Gulati, Neha, et al.
Publicado: (2013)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Intranasal administration of acetylcholinesterase inhibitors
por: Costantino, Henry R, et al.
Publicado: (2008)

Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
por: Michelini, Zuleika, et al.
Publicado: (2017)

Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice
por: To, Eunice E., et al.
Publicado: (2019)

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier
por: Gao, Xiaoyi, et al.
Publicado: (2021)

Intranasal Administration of Agomir-let-7i Improves Cognitive Function in Mice with Traumatic Brain Injury
por: He, Xuan-Cheng, et al.
Publicado: (2022)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Intranasal Administration of miR-146a Agomir Rescued the Pathological Process and Cognitive Impairment in an AD Mouse Model
por: Mai, Hui, et al.
Publicado: (2019)

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Novel mouse model of steroid-resistant allergic rhinitis by repeated intranasal administration of OVA
por: Izumi, Kazunari, et al.
Publicado: (2015)

Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020)

Intranasal administration of immunogenic poly-epitope from influenza H1N1 and H3N2 viruses adjuvanted with chitin and chitosan microparticles in BALB/c mice
por: Sadeghi, Sahar, et al.
Publicado: (2021)

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
por: Jin, Zhiyu, et al.
Publicado: (2022)

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A, et al.
Publicado: (2017)

Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration
por: Zhang, Xingjian, et al.
Publicado: (2023)

Intranasal Immunization of Baculovirus Displayed Hemagglutinin Confers Complete Protection against Mouse Adapted Highly Pathogenic H7N7 Reassortant Influenza Virus
por: Rajesh Kumar, Subaschandrabose, et al.
Publicado: (2013)

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
por: Zhou, Runhong, et al.
Publicado: (2021)

Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1–2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens
por: Song, Li, et al.
Publicado: (2017)

Intranasal Administration of Mammary Tumour Milk Factor
por: Begg, A. M.
Publicado: (1949)

Design and Efficacy of Nanogels Formulations for Intranasal Administration
por: Aderibigbe, Blessing A., et al.
Publicado: (2018)

Inadequate quality of administration of intranasal corticosteroid sprays
por: Rollema, Corine, et al.
Publicado: (2019)

Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
por: Nedorubov, Andrey Anatolievich, et al.
Publicado: (2019)

Intranasal Administration for Pain: Oxytocin and Other Polypeptides
por: Bharadwaj, Vimala N., et al.
Publicado: (2021)

Intranasal Treatment of Ferrets with Inert Bacterial Spores Reduces Disease Caused by a Challenging H7N9 Avian Influenza Virus
por: James, Joe, et al.
Publicado: (2022)

Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions
por: Donega, Vanessa, et al.
Publicado: (2014)

Elevated Salivary Levels of Oxytocin Persist More than 7 h after Intranasal Administration
por: van IJzendoorn, Marinus H., et al.
Publicado: (2012)

The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles
por: Tarabichi, Y., et al.
Publicado: (2015)

Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications
por: Gagliardi, Mariacristina, et al.
Publicado: (2023)

Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines
por: Xu, Kangwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_85jft9f3e16cp3k9cufguoba57